loadpatents
Patent applications and USPTO patent grants for GONG; Xiaojuan.The latest application filed is for "cytotoxic particles for targeting p2x7 receptor".
Patent | Date |
---|---|
Cytotoxic Particles for Targeting P2X7 Receptor App 20220249692 - GONG; Xiaojuan ;   et al. | 2022-08-11 |
Cytotoxic particles for targeting P2X7 receptor Grant 11,260,131 - Gong , et al. March 1, 2 | 2022-03-01 |
Platinum-based Amphiphile Prodrugs App 20210275489 - MOGHADDAM; Minoo Jalili ;   et al. | 2021-09-09 |
Gemcitabine Amphiphile Prodrugs App 20210238214 - MOGHADDAM; Minoo Jalili ;   et al. | 2021-08-05 |
Cytotoxic Particles App 20190201545 - GONG; Xiaojuan ;   et al. | 2019-07-04 |
Amphiphile Prodrugs App 20140094426 - Drummond; Calum John ;   et al. | 2014-04-03 |
Amphiphile prodrugs Grant 8,603,999 - Drummond , et al. December 10, 2 | 2013-12-10 |
Amphiphile Prodrugs App 20110301114 - Drummond; Calum John ;   et al. | 2011-12-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.